SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹488 Cr | ₹1,136 Cr | ₹852 Cr | ₹918 Cr | ₹345 Cr |
What is the latest Net Current Assets ratio of SUVEN PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹488 Cr |
| Mar2024 | ₹1,136 Cr |
| Mar2023 | ₹852 Cr |
| Mar2022 | ₹918 Cr |
| Mar2021 | ₹345 Cr |
How is Net Current Assets of SUVEN PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹488 Cr | -57.03 | |
| Mar2024 | ₹1,136 Cr | 33.27 | |
| Mar2023 | ₹852 Cr | -7.12 | |
| Mar2022 | ₹918 Cr | 165.95 | |
| Mar2021 | ₹345 Cr | - | |
Compare Net Current Assets of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹20,497.8 Cr | 1% | -4.4% | -54.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,884.0 Cr | -0.5% | -1.9% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,442.0 Cr | 1.8% | 1.3% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,770.0 Cr | 2% | 2.4% | 11.2% | Stock Analytics | |
| CIPLA | ₹120,871.0 Cr | -0.2% | -0.7% | 1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,693.0 Cr | -1% | 2.5% | -4.4% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | 1% |
-4.4% |
-54.6% |
| SENSEX | 1% |
0.6% |
7.8% |
You may also like the below Video Courses